1,3-Bis(4-hydroxyphenoxy)benzene>98.0%(GC)5g

2-Methylthiazole-5-carbonitrile, 95.0%, 250mg

Azepane-4-carboxylic acid, 95.0%, 100mg

3-(3-Cyanobenzoyl)-4-methylpyridine, 97.0%, 1g

2-(2-chloroethyl)-6-methyl-1H-benzimidazole hydrochloride, 95.0%, 5g

Methyl 6-nitroindole-3-carboxylate, 98%, 100mg

N-Acetylglycine, min. 99%, for biochemistry, 100 g, plastic packaging.

Diethyl (S)-(2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate, 98%, 1g

3-(2-ethyl-1-piperidinyl)propanoic acid hydrochloride, 95.0%, 1g

6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridine, 97.0%, 25g

(2E)-1-(3-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one, 95.0%, 2g

2-Bromo-3-fluorobenzonitrile, 98.0%, 10g

anti-GAPDH mouse monoclonal, clone 6C5, 0.2 ml